Last reviewed · How we verify
Edema in nephrotic syndrome with inadequate response to other treatments
Approved treatments
- Aldactone · Pfizer Inc.
Aldosterone antagonist causing increased sodium and water excretion while retaining potassium.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Edema in nephrotic syndrome with inadequate response to other treatments patent landscape — cliff calendar, originator estates, attackable patents
- Edema in nephrotic syndrome with inadequate response to other treatments treatment landscape brief
- Edema in nephrotic syndrome with inadequate response to other treatments treatment updates RSS
Frequently asked questions about Edema in nephrotic syndrome with inadequate response to other treatments
What drugs treat Edema in nephrotic syndrome with inadequate response to other treatments?
Tracked treatments include Aldactone.
What is the treatment for Edema in nephrotic syndrome with inadequate response to other treatments?
Standard treatment for Edema in nephrotic syndrome with inadequate response to other treatments includes Aldactone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Edema in nephrotic syndrome with inadequate response to other treatments patent cliff · Edema in nephrotic syndrome with inadequate response to other treatments CI report
- Treatment: Aldactone · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing